Serveur d'exploration sur les mitochondries dans l'oxydoréduction chez les plantes

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Changes in Plasma Acylcarnitine and Lysophosphatidylcholine Levels Following a High-Fructose Diet: A Targeted Metabolomics Study in Healthy Women.

Identifieur interne : 000234 ( Main/Exploration ); précédent : 000233; suivant : 000235

Changes in Plasma Acylcarnitine and Lysophosphatidylcholine Levels Following a High-Fructose Diet: A Targeted Metabolomics Study in Healthy Women.

Auteurs : Anita Gonzalez-Granda [Allemagne] ; Antje Damms-Machado [Allemagne] ; Maryam Basrai [Allemagne] ; Stephan C. Bischoff [Allemagne]

Source :

RBID : pubmed:30200659

Descripteurs français

English descriptors

Abstract

BACKGROUND

The consumption of high amounts of fructose is associated with metabolic diseases. However, the underlying mechanisms are largely unknown.

OBJECTIVE

To determine the effects of high fructose intake on plasma metabolomics.

STUDY DESIGN

We enrolled 12 healthy volunteers (six lean and six obese women, age 24⁻35 years) in a crossover intervention study. All participants carried out three diets: (1) low fructose (<10 g/day); (2) high fructose (100 g/day) from natural food sources (fruit); and (3) high fructose (100 g/day) from high fructose syrup (HFS).

OUTCOME MEASURES

The primary outcome was changes in plasma metabolites measured by targeted metabolomics.

RESULTS

High compared to low fructose diets caused a marked metabolite class separation, especially because of changes in acylcarnitine and lysophosphatidylcholine levels. Both high fructose diets resulted in a decrease in mean acylcarnitine levels in all subjects, and an increase in mean lysophosphatidylcholine and diacyl-phosphatidylcholine levels in obese individuals. Medium chain acylcarnitines were negatively correlated with serum levels of liver enzymes and with the fatty liver index.

DISCUSSION

The metabolic shifts induced by high fructose consumption suggest an inhibition of mitochondrial β-oxidation and an increase in lipid peroxidation. The effects tended to be more pronounced following the HFS than the fruit diet.


DOI: 10.3390/nu10091254
PubMed: 30200659
PubMed Central: PMC6165514


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Changes in Plasma Acylcarnitine and Lysophosphatidylcholine Levels Following a High-Fructose Diet: A Targeted Metabolomics Study in Healthy Women.</title>
<author>
<name sortKey="Gonzalez Granda, Anita" sort="Gonzalez Granda, Anita" uniqKey="Gonzalez Granda A" first="Anita" last="Gonzalez-Granda">Anita Gonzalez-Granda</name>
<affiliation wicri:level="4">
<nlm:affiliation>Institute of Clinical Nutrition, University of Hohenheim, Fruwirthstr 12, 70599 Stuttgart, Germany. anita.gonzalez_granda@uni-hohenheim.de.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Institute of Clinical Nutrition, University of Hohenheim, Fruwirthstr 12, 70599 Stuttgart</wicri:regionArea>
<placeName>
<region type="land" nuts="1">Bade-Wurtemberg</region>
<region type="district" nuts="2">District de Stuttgart</region>
<settlement type="city">Stuttgart</settlement>
</placeName>
<orgName type="university">Université de Hohenheim</orgName>
</affiliation>
</author>
<author>
<name sortKey="Damms Machado, Antje" sort="Damms Machado, Antje" uniqKey="Damms Machado A" first="Antje" last="Damms-Machado">Antje Damms-Machado</name>
<affiliation wicri:level="4">
<nlm:affiliation>Institute of Clinical Nutrition, University of Hohenheim, Fruwirthstr 12, 70599 Stuttgart, Germany. a.damms-machado@uni-hohenheim.de.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Institute of Clinical Nutrition, University of Hohenheim, Fruwirthstr 12, 70599 Stuttgart</wicri:regionArea>
<placeName>
<region type="land" nuts="1">Bade-Wurtemberg</region>
<region type="district" nuts="2">District de Stuttgart</region>
<settlement type="city">Stuttgart</settlement>
</placeName>
<orgName type="university">Université de Hohenheim</orgName>
</affiliation>
</author>
<author>
<name sortKey="Basrai, Maryam" sort="Basrai, Maryam" uniqKey="Basrai M" first="Maryam" last="Basrai">Maryam Basrai</name>
<affiliation wicri:level="4">
<nlm:affiliation>Institute of Clinical Nutrition, University of Hohenheim, Fruwirthstr 12, 70599 Stuttgart, Germany. m.basrai@uni-hohenheim.de.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Institute of Clinical Nutrition, University of Hohenheim, Fruwirthstr 12, 70599 Stuttgart</wicri:regionArea>
<placeName>
<region type="land" nuts="1">Bade-Wurtemberg</region>
<region type="district" nuts="2">District de Stuttgart</region>
<settlement type="city">Stuttgart</settlement>
</placeName>
<orgName type="university">Université de Hohenheim</orgName>
</affiliation>
</author>
<author>
<name sortKey="Bischoff, Stephan C" sort="Bischoff, Stephan C" uniqKey="Bischoff S" first="Stephan C" last="Bischoff">Stephan C. Bischoff</name>
<affiliation wicri:level="4">
<nlm:affiliation>Institute of Clinical Nutrition, University of Hohenheim, Fruwirthstr 12, 70599 Stuttgart, Germany. bischoff.stephan@uni-hohenheim.de.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Institute of Clinical Nutrition, University of Hohenheim, Fruwirthstr 12, 70599 Stuttgart</wicri:regionArea>
<placeName>
<region type="land" nuts="1">Bade-Wurtemberg</region>
<region type="district" nuts="2">District de Stuttgart</region>
<settlement type="city">Stuttgart</settlement>
</placeName>
<orgName type="university">Université de Hohenheim</orgName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2018">2018</date>
<idno type="RBID">pubmed:30200659</idno>
<idno type="pmid">30200659</idno>
<idno type="doi">10.3390/nu10091254</idno>
<idno type="pmc">PMC6165514</idno>
<idno type="wicri:Area/Main/Corpus">000183</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000183</idno>
<idno type="wicri:Area/Main/Curation">000183</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000183</idno>
<idno type="wicri:Area/Main/Exploration">000183</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Changes in Plasma Acylcarnitine and Lysophosphatidylcholine Levels Following a High-Fructose Diet: A Targeted Metabolomics Study in Healthy Women.</title>
<author>
<name sortKey="Gonzalez Granda, Anita" sort="Gonzalez Granda, Anita" uniqKey="Gonzalez Granda A" first="Anita" last="Gonzalez-Granda">Anita Gonzalez-Granda</name>
<affiliation wicri:level="4">
<nlm:affiliation>Institute of Clinical Nutrition, University of Hohenheim, Fruwirthstr 12, 70599 Stuttgart, Germany. anita.gonzalez_granda@uni-hohenheim.de.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Institute of Clinical Nutrition, University of Hohenheim, Fruwirthstr 12, 70599 Stuttgart</wicri:regionArea>
<placeName>
<region type="land" nuts="1">Bade-Wurtemberg</region>
<region type="district" nuts="2">District de Stuttgart</region>
<settlement type="city">Stuttgart</settlement>
</placeName>
<orgName type="university">Université de Hohenheim</orgName>
</affiliation>
</author>
<author>
<name sortKey="Damms Machado, Antje" sort="Damms Machado, Antje" uniqKey="Damms Machado A" first="Antje" last="Damms-Machado">Antje Damms-Machado</name>
<affiliation wicri:level="4">
<nlm:affiliation>Institute of Clinical Nutrition, University of Hohenheim, Fruwirthstr 12, 70599 Stuttgart, Germany. a.damms-machado@uni-hohenheim.de.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Institute of Clinical Nutrition, University of Hohenheim, Fruwirthstr 12, 70599 Stuttgart</wicri:regionArea>
<placeName>
<region type="land" nuts="1">Bade-Wurtemberg</region>
<region type="district" nuts="2">District de Stuttgart</region>
<settlement type="city">Stuttgart</settlement>
</placeName>
<orgName type="university">Université de Hohenheim</orgName>
</affiliation>
</author>
<author>
<name sortKey="Basrai, Maryam" sort="Basrai, Maryam" uniqKey="Basrai M" first="Maryam" last="Basrai">Maryam Basrai</name>
<affiliation wicri:level="4">
<nlm:affiliation>Institute of Clinical Nutrition, University of Hohenheim, Fruwirthstr 12, 70599 Stuttgart, Germany. m.basrai@uni-hohenheim.de.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Institute of Clinical Nutrition, University of Hohenheim, Fruwirthstr 12, 70599 Stuttgart</wicri:regionArea>
<placeName>
<region type="land" nuts="1">Bade-Wurtemberg</region>
<region type="district" nuts="2">District de Stuttgart</region>
<settlement type="city">Stuttgart</settlement>
</placeName>
<orgName type="university">Université de Hohenheim</orgName>
</affiliation>
</author>
<author>
<name sortKey="Bischoff, Stephan C" sort="Bischoff, Stephan C" uniqKey="Bischoff S" first="Stephan C" last="Bischoff">Stephan C. Bischoff</name>
<affiliation wicri:level="4">
<nlm:affiliation>Institute of Clinical Nutrition, University of Hohenheim, Fruwirthstr 12, 70599 Stuttgart, Germany. bischoff.stephan@uni-hohenheim.de.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Institute of Clinical Nutrition, University of Hohenheim, Fruwirthstr 12, 70599 Stuttgart</wicri:regionArea>
<placeName>
<region type="land" nuts="1">Bade-Wurtemberg</region>
<region type="district" nuts="2">District de Stuttgart</region>
<settlement type="city">Stuttgart</settlement>
</placeName>
<orgName type="university">Université de Hohenheim</orgName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Nutrients</title>
<idno type="eISSN">2072-6643</idno>
<imprint>
<date when="2018" type="published">2018</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adult (MeSH)</term>
<term>Biomarkers (blood)</term>
<term>Carnitine (analogs & derivatives)</term>
<term>Carnitine (blood)</term>
<term>Cross-Over Studies (MeSH)</term>
<term>Diet, Carbohydrate-Restricted (MeSH)</term>
<term>Dietary Sugars (administration & dosage)</term>
<term>Dietary Sugars (blood)</term>
<term>Female (MeSH)</term>
<term>Fruit (MeSH)</term>
<term>Germany (MeSH)</term>
<term>High Fructose Corn Syrup (administration & dosage)</term>
<term>High Fructose Corn Syrup (blood)</term>
<term>Humans (MeSH)</term>
<term>Lipid Peroxidation (MeSH)</term>
<term>Lysophosphatidylcholines (blood)</term>
<term>Metabolomics (methods)</term>
<term>Mitochondria (metabolism)</term>
<term>Obesity (blood)</term>
<term>Oxidation-Reduction (MeSH)</term>
<term>Time Factors (MeSH)</term>
<term>Vegetables (MeSH)</term>
<term>Young Adult (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adulte (MeSH)</term>
<term>Allemagne (MeSH)</term>
<term>Carnitine (analogues et dérivés)</term>
<term>Carnitine (sang)</term>
<term>Facteurs temps (MeSH)</term>
<term>Femelle (MeSH)</term>
<term>Fruit (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Jeune adulte (MeSH)</term>
<term>Lysolécithine (sang)</term>
<term>Légumes (MeSH)</term>
<term>Marqueurs biologiques (sang)</term>
<term>Mitochondries (métabolisme)</term>
<term>Métabolomique (méthodes)</term>
<term>Obésité (sang)</term>
<term>Oxydoréduction (MeSH)</term>
<term>Peroxydation lipidique (MeSH)</term>
<term>Régime pauvre en glucides (MeSH)</term>
<term>Sirop de maïs à haute teneur en fructose (administration et posologie)</term>
<term>Sirop de maïs à haute teneur en fructose (sang)</term>
<term>Sucres alimentaires (administration et posologie)</term>
<term>Sucres alimentaires (sang)</term>
<term>Études croisées (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en">
<term>Dietary Sugars</term>
<term>High Fructose Corn Syrup</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en">
<term>Carnitine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en">
<term>Biomarkers</term>
<term>Carnitine</term>
<term>Dietary Sugars</term>
<term>High Fructose Corn Syrup</term>
<term>Lysophosphatidylcholines</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en">
<term>Germany</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr">
<term>Sirop de maïs à haute teneur en fructose</term>
<term>Sucres alimentaires</term>
</keywords>
<keywords scheme="MESH" qualifier="analogues et dérivés" xml:lang="fr">
<term>Carnitine</term>
</keywords>
<keywords scheme="MESH" qualifier="blood" xml:lang="en">
<term>Obesity</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Mitochondria</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en">
<term>Metabolomics</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Mitochondries</term>
</keywords>
<keywords scheme="MESH" qualifier="méthodes" xml:lang="fr">
<term>Métabolomique</term>
</keywords>
<keywords scheme="MESH" qualifier="sang" xml:lang="fr">
<term>Carnitine</term>
<term>Lysolécithine</term>
<term>Marqueurs biologiques</term>
<term>Obésité</term>
<term>Sirop de maïs à haute teneur en fructose</term>
<term>Sucres alimentaires</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adult</term>
<term>Cross-Over Studies</term>
<term>Diet, Carbohydrate-Restricted</term>
<term>Female</term>
<term>Fruit</term>
<term>Humans</term>
<term>Lipid Peroxidation</term>
<term>Oxidation-Reduction</term>
<term>Time Factors</term>
<term>Vegetables</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adulte</term>
<term>Allemagne</term>
<term>Facteurs temps</term>
<term>Femelle</term>
<term>Fruit</term>
<term>Humains</term>
<term>Jeune adulte</term>
<term>Légumes</term>
<term>Oxydoréduction</term>
<term>Peroxydation lipidique</term>
<term>Régime pauvre en glucides</term>
<term>Études croisées</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr">
<term>Allemagne</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>
<b>BACKGROUND</b>
</p>
<p>The consumption of high amounts of fructose is associated with metabolic diseases. However, the underlying mechanisms are largely unknown.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>OBJECTIVE</b>
</p>
<p>To determine the effects of high fructose intake on plasma metabolomics.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>STUDY DESIGN</b>
</p>
<p>We enrolled 12 healthy volunteers (six lean and six obese women, age 24⁻35 years) in a crossover intervention study. All participants carried out three diets: (1) low fructose (<10 g/day); (2) high fructose (100 g/day) from natural food sources (fruit); and (3) high fructose (100 g/day) from high fructose syrup (HFS).</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>OUTCOME MEASURES</b>
</p>
<p>The primary outcome was changes in plasma metabolites measured by targeted metabolomics.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>RESULTS</b>
</p>
<p>High compared to low fructose diets caused a marked metabolite class separation, especially because of changes in acylcarnitine and lysophosphatidylcholine levels. Both high fructose diets resulted in a decrease in mean acylcarnitine levels in all subjects, and an increase in mean lysophosphatidylcholine and diacyl-phosphatidylcholine levels in obese individuals. Medium chain acylcarnitines were negatively correlated with serum levels of liver enzymes and with the fatty liver index.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>DISCUSSION</b>
</p>
<p>The metabolic shifts induced by high fructose consumption suggest an inhibition of mitochondrial β-oxidation and an increase in lipid peroxidation. The effects tended to be more pronounced following the HFS than the fruit diet.</p>
</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">30200659</PMID>
<DateCompleted>
<Year>2018</Year>
<Month>12</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>12</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Electronic">
<Journal>
<ISSN IssnType="Electronic">2072-6643</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>10</Volume>
<Issue>9</Issue>
<PubDate>
<Year>2018</Year>
<Month>Sep</Month>
<Day>06</Day>
</PubDate>
</JournalIssue>
<Title>Nutrients</Title>
<ISOAbbreviation>Nutrients</ISOAbbreviation>
</Journal>
<ArticleTitle>Changes in Plasma Acylcarnitine and Lysophosphatidylcholine Levels Following a High-Fructose Diet: A Targeted Metabolomics Study in Healthy Women.</ArticleTitle>
<ELocationID EIdType="pii" ValidYN="Y">E1254</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.3390/nu10091254</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The consumption of high amounts of fructose is associated with metabolic diseases. However, the underlying mechanisms are largely unknown.</AbstractText>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To determine the effects of high fructose intake on plasma metabolomics.</AbstractText>
<AbstractText Label="STUDY DESIGN" NlmCategory="METHODS">We enrolled 12 healthy volunteers (six lean and six obese women, age 24⁻35 years) in a crossover intervention study. All participants carried out three diets: (1) low fructose (<10 g/day); (2) high fructose (100 g/day) from natural food sources (fruit); and (3) high fructose (100 g/day) from high fructose syrup (HFS).</AbstractText>
<AbstractText Label="OUTCOME MEASURES" NlmCategory="METHODS">The primary outcome was changes in plasma metabolites measured by targeted metabolomics.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">High compared to low fructose diets caused a marked metabolite class separation, especially because of changes in acylcarnitine and lysophosphatidylcholine levels. Both high fructose diets resulted in a decrease in mean acylcarnitine levels in all subjects, and an increase in mean lysophosphatidylcholine and diacyl-phosphatidylcholine levels in obese individuals. Medium chain acylcarnitines were negatively correlated with serum levels of liver enzymes and with the fatty liver index.</AbstractText>
<AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">The metabolic shifts induced by high fructose consumption suggest an inhibition of mitochondrial β-oxidation and an increase in lipid peroxidation. The effects tended to be more pronounced following the HFS than the fruit diet.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Gonzalez-Granda</LastName>
<ForeName>Anita</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Institute of Clinical Nutrition, University of Hohenheim, Fruwirthstr 12, 70599 Stuttgart, Germany. anita.gonzalez_granda@uni-hohenheim.de.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Damms-Machado</LastName>
<ForeName>Antje</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Institute of Clinical Nutrition, University of Hohenheim, Fruwirthstr 12, 70599 Stuttgart, Germany. a.damms-machado@uni-hohenheim.de.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Basrai</LastName>
<ForeName>Maryam</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Institute of Clinical Nutrition, University of Hohenheim, Fruwirthstr 12, 70599 Stuttgart, Germany. m.basrai@uni-hohenheim.de.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bischoff</LastName>
<ForeName>Stephan C</ForeName>
<Initials>SC</Initials>
<AffiliationInfo>
<Affiliation>Institute of Clinical Nutrition, University of Hohenheim, Fruwirthstr 12, 70599 Stuttgart, Germany. bischoff.stephan@uni-hohenheim.de.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>FKZ: 01GI0843</GrantID>
<Agency>Bundesministerium für Bildung und Forschung</Agency>
<Country></Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016430">Clinical Trial</PublicationType>
<PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2018</Year>
<Month>09</Month>
<Day>06</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Switzerland</Country>
<MedlineTA>Nutrients</MedlineTA>
<NlmUniqueID>101521595</NlmUniqueID>
<ISSNLinking>2072-6643</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000073417">Dietary Sugars</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D066248">High Fructose Corn Syrup</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008244">Lysophosphatidylcholines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C116917">acylcarnitine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>S7UI8SM58A</RegistryNumber>
<NameOfSubstance UI="D002331">Carnitine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002331" MajorTopicYN="N">Carnitine</DescriptorName>
<QualifierName UI="Q000031" MajorTopicYN="Y">analogs & derivatives</QualifierName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018592" MajorTopicYN="N">Cross-Over Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D050528" MajorTopicYN="N">Diet, Carbohydrate-Restricted</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000073417" MajorTopicYN="N">Dietary Sugars</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005638" MajorTopicYN="Y">Fruit</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005858" MajorTopicYN="N" Type="Geographic">Germany</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D066248" MajorTopicYN="N">High Fructose Corn Syrup</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015227" MajorTopicYN="N">Lipid Peroxidation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008244" MajorTopicYN="N">Lysophosphatidylcholines</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D055432" MajorTopicYN="N">Metabolomics</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009765" MajorTopicYN="N">Obesity</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010084" MajorTopicYN="N">Oxidation-Reduction</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014675" MajorTopicYN="Y">Vegetables</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">fructose</Keyword>
<Keyword MajorTopicYN="N">liver disease</Keyword>
<Keyword MajorTopicYN="N">metabolic syndrome</Keyword>
<Keyword MajorTopicYN="N">targeted metabolomics</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2018</Year>
<Month>07</Month>
<Day>23</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2018</Year>
<Month>08</Month>
<Day>20</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2018</Year>
<Month>08</Month>
<Day>30</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2018</Year>
<Month>9</Month>
<Day>12</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2018</Year>
<Month>9</Month>
<Day>12</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2018</Year>
<Month>12</Month>
<Day>18</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">30200659</ArticleId>
<ArticleId IdType="pii">nu10091254</ArticleId>
<ArticleId IdType="doi">10.3390/nu10091254</ArticleId>
<ArticleId IdType="pmc">PMC6165514</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>J Nutr. 2009 Jun;139(6):1073-81</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19369366</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nutr Metab Cardiovasc Dis. 2013 Jun;23(6):536-42</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22386006</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Food Sci. 2011 Jan-Feb;76(1):R6-R15</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21535705</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Nutr Biochem. 2012 Mar;23(3):203-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22129639</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Food Res Int. 2018 May;107:346-352</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29580494</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Opin Lipidol. 2008 Feb;19(1):16-24</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18196982</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nutr Rev. 2005 May;63(5):133-57</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15971409</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Nutr. 2009 Jun;139(6):1257S-1262S</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19403705</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Sci (Lond). 2012 Dec;123(12):681-92</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22738259</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Physiol Biochem. 2017 Dec 20;:1-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29260581</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Clin Nutr. 2011 Aug;94(2):479-85</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21677052</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Lipid Res. 2013 Oct;54(10):2898-908</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23868910</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nutrition. 2014 May;30(5):503-10</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24698343</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Endocrinol Metab. 2009 May;94(5):1562-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19208729</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Med Genet C Semin Med Genet. 2006 May 15;142C(2):77-85</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16602102</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Physiol Gastrointest Liver Physiol. 2001 Jun;280(6):G1227-33</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11352816</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2012;7(7):e41456</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22848500</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Diabetes. 2013 Jan;62(1):1-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23258903</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci Rep. 2011;1:79</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22355598</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Physiol Biochem. 2012 Dec;68(4):701-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22351038</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Hepatology. 2007 Mar;45(3):778-88</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17326204</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Clin Nutr. 2012 May;66(5):591-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22190137</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2017 Mar 9;12(3):e0173615</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28278231</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Breath Res. 2008 Dec;2(4):046002</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21386189</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Atherosclerosis. 1998 Apr;137(2):351-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9622278</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2006 Dec 14;444(7121):860-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17167474</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Gastroenterol. 2006 Nov 02;6:33</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17081293</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nutrients. 2017 Sep 16;9(9):null</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28926951</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Medscape J Med. 2008 Jul 09;10(7):160</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18769702</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Circulation. 2003 Dec 23;108(25):3128-33</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14638540</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Atherosclerosis. 2010 Jan;208(1):10-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19570538</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Clin Nutr. 2012 Feb;66(2):201-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21952692</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Can J Gastroenterol. 2008 Oct;22(10):811-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18925303</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Clin Nutr. 2002 Nov;76(5):911-22</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12399260</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Food Chem Toxicol. 2012 Jun;50(6):2135-41</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22465803</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Tissue Cell. 2001 Jun;33(3):233-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11469536</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Crit Rev Food Sci Nutr. 2017 Jan 2;57(1):59-81</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25830345</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Syst Biol. 2009 Jan 06;3:2</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19126203</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2007 Feb 14;2(2):e218</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17299598</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>FASEB J. 2015 Jan;29(1):336-45</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25342132</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Diabetes Res Clin Pract. 2004 Jul;65(1):7-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15163472</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Talanta. 2018 Aug 1;185:483-490</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29759231</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Diabetes. 2005 Jul;54(7):1907-13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15983189</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2008 Mar 7;283(10):6428-37</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18165686</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2005 Apr 21;352(16):1685-95</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15843671</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Obesity (Silver Spring). 2017 Sep;25(9):1618-1624</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28758372</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Nutr. 2015 Mar;54(2):173-81</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24740590</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Hepatol. 2008 Jun;48(6):983-92</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18395289</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Obesity (Silver Spring). 2010 Sep;18(9):1695-700</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20111019</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Am Heart Assoc. 2015 Sep 10;4(9):e001700</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26358358</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Clin Nutr. 2016 Dec;104(6):1562-1576</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27935520</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Br J Nutr. 2008 Aug;100(2):393-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18205992</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Stroke. 2008 May;39(5):1448-55</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18356547</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>AJR Am J Roentgenol. 2009 Apr;192(4):909-14</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19304694</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Clin Nutr. 2008 May;87(5):1194-203</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18469239</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Nutr. 2004 Sep;134(9):2293-300</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15333719</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Gastroenterol. 2007 Dec;102(12):2716-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18042105</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Br J Nutr. 2007 Dec;98(6):1170-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17640415</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Clin Nutr. 2004 Apr;79(4):537-43</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15051594</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Nutr. 2017 May;147(5):770-780</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28356436</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Med. 2008 Oct;14(10):1015-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18841134</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Gut. 1995 Jun;36(6):825-30</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7615267</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Allemagne</li>
</country>
<region>
<li>Bade-Wurtemberg</li>
<li>District de Stuttgart</li>
</region>
<settlement>
<li>Stuttgart</li>
</settlement>
<orgName>
<li>Université de Hohenheim</li>
</orgName>
</list>
<tree>
<country name="Allemagne">
<region name="Bade-Wurtemberg">
<name sortKey="Gonzalez Granda, Anita" sort="Gonzalez Granda, Anita" uniqKey="Gonzalez Granda A" first="Anita" last="Gonzalez-Granda">Anita Gonzalez-Granda</name>
</region>
<name sortKey="Basrai, Maryam" sort="Basrai, Maryam" uniqKey="Basrai M" first="Maryam" last="Basrai">Maryam Basrai</name>
<name sortKey="Bischoff, Stephan C" sort="Bischoff, Stephan C" uniqKey="Bischoff S" first="Stephan C" last="Bischoff">Stephan C. Bischoff</name>
<name sortKey="Damms Machado, Antje" sort="Damms Machado, Antje" uniqKey="Damms Machado A" first="Antje" last="Damms-Machado">Antje Damms-Machado</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/MitoPlantRedoxV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000234 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000234 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    MitoPlantRedoxV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:30200659
   |texte=   Changes in Plasma Acylcarnitine and Lysophosphatidylcholine Levels Following a High-Fructose Diet: A Targeted Metabolomics Study in Healthy Women.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:30200659" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a MitoPlantRedoxV1 

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat Nov 21 12:18:52 2020. Site generation: Sat Nov 21 12:19:22 2020